CORONARY ARTERY BYPASS GRAFTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, request sample copy

North America dominates the global coronary artery bypass grafting market with an estimated market share of 39.3% in 2024. With a highly developed healthcare system and growing prevalence of cardiovascular diseases, the U.S. accounts for the largest share within the region. Favorable reimbursement policies for cardiac procedures have encouraged the adoption of CABG. Moreover, presence of leading medical device manufacturers influences clinical practice and innovation within the U.S. Hospitals in the U.S. are well-equipped to perform CABG procedures and trained cardiothoracic surgeons are readily available nationwide.

Universal healthcare coverage enables broader access to treatment. Guidelines recommend CABG as the standard of care for select patient groups, driving the market growth. North America faces challenges of an aging population and rising obesity rates that increase the burden of heart disease over the long term.

Asia Pacific is poised to emerge as the fastest growing regional market for coronary artery bypass grafting. Economies like India and China are industrializing rapidly and experiencing growth in lifestyle diseases. While rudimentary cardiac care exists, cardiovascular specialists are actively working to spread awareness and enhance capacity. Governments provide some level of healthcare coverage that boosts demand for CABG from an expanding middle class. Foreign investment and medical tourism additionally stimulate the supply side infrastructure in Asia Pacific. The combination of unmet needs, improving standards and supportive policy frameworks can propel this region to become a global hotspot.